Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-02-27 @ 8:30 AM
Study NCT ID:
NCT05549505
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2022-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Sponsor:
Arvinas Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Early breast cancer | View |
| None | Localized breast cancer | View |
| None | Untreated breast cancer | View |
| None | Pre-operative breast cancer | View |
| None | Treatment-naïve breast cancer | View |
| None | Neoadjuvant | View |
| None | Estrogen receptor | View |
| None | Estrogen receptor positive | View |
| None | ER+ | View |
| None | Hormone positive | View |
| None | Hormone receptor positive | View |
| None | HR+ | View |
| None | human epidermal growth factor receptor 2 negative | View |
| None | HER2- | View |
| None | ARV-471 | View |
| None | Anastrozole | View |
| None | Arimidex | View |
| None | Aromatase inhibitor | View |
| None | Vepdegestrant | View |
| None | PF-07850327 | View |